LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Saliva Test Detects GHB and Alcohol Poisonings

By LabMedica International staff writers
Posted on 19 Jan 2016
Print article
Image: Differential mobility spectra extracted from the GC-DMS response surface for 1,3-propandiol (D) and GHB (E) (Photo courtesy of Loughborough University).
Image: Differential mobility spectra extracted from the GC-DMS response surface for 1,3-propandiol (D) and GHB (E) (Photo courtesy of Loughborough University).
Image: The Sionex microanalyzer trace chemical detection system (Photo courtesy of Sionex Corporation).
Image: The Sionex microanalyzer trace chemical detection system (Photo courtesy of Sionex Corporation).
A saliva-based test has been developed that offers the potential to screen for poisons commonly associated with the cheap or imitation manufacture of alcohol, and γ-hydroxybutyric acid, the so-called “date rape” drug GHB.

Treatment of poisoning from the consumption of ethanol and the management of the intoxicated patient represents a significant burden on many health services. Further, poisoning from the consumption of other alcohols, notably methanol and ethylene glycol, occurs sporadically and from time to time outbreaks occur where food, drink or medicines are contaminated, resulting in significant mortality.

Scientists at Loughborough University (UK) and the University of Cordoba (Spain) added to the fresh saliva of volunteers and used a polydimethylsiloxane (PDMS) oral sampler to extract methanol, ethanol, ethylene glycol, 1,3-propandiol and γ-hydroxybutyric acid. The compounds were detected using gas chromatography-differential mobility spectrometry (GC-DMS). The extracted compounds were recovered by thermal desorption, isolated by gas chromatography and detected with differential mobility spectrometry, operating with a programmed dispersion field.

Calibration of the DMS under optimized conditions was undertaken using gas chromatography to introduce known on-column masses of the analytes injected in a solution of dichloromethane. The DMS used in the study was a planar device (SDP-1, Sionex Corporation, Bedford, MA, USA). Once the analytes had been added, the saliva standards were homogenized. Immediately after this had been done, a PDMS-coated titanium cartridge was removed from its sealed thermal desorption tube and placed into the vial, which was then sealed immediately.

C.L. Paul Thomas, PhD, a professor of Analytical Science, and coauthor of the study, said, “Many people attending accident and emergency departments have some kind of alcohol-related issue, particularly at the weekends. We're aiming to develop a test that is as simple as taking temperature with a thermometer that detects when patients are more than just drunk. We were surprised at the ease at which we could detect γ-hydroxybutyric acid. It's both a polar and acidic molecule, but it turned out to be easy to detect, even at the low concentrations we were studying.” The scientists are now working on running trials of their test in a clinical setting, on patients in emergency departments. The study was published on January 8, 2016, in the Journal of Breath Research.

Related Links:

Loughborough University 
University of Cordoba 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more